Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

REPLIGEN CORP Director's Dealing 2018

Jul 31, 2018

30826_dirs_2018-07-30_63f12dcf-d45d-4dea-b985-4b657ab893d4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2018-07-26

Reporting Person: EDDLEMAN ROY T (10% Owner)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-07-26 Call option(obligation to sell) $53.9372 S 1 Disposed 2019-07-26 Common Stock (250000) Indirect
2018-07-26 Put option (right to sell) $43.891 P 1 Acquired 2019-07-26 Common Stock (250000) Indirect

Footnotes

F1: The reporting person entered into a so-called zero-cost collar arrangement pursuant to which he wrote a covered call option and purchased a put option. Only one of the options can be "in the money" on the expiration date, at which time the in-the-money option will be exercised (or settled in cash), and the other option will expire. If neither option is in the money on the expiration date, both will expire.

F2: The securities shown are held of record by the Roy T. Eddleman Living Trust UAD 8-7-2000, of which the reporting person is the sole trustee and, as such, has investment and voting control over such securities.